Real-time Estimate Cboe Europe 06:37:19 2023-09-22 am EDT |
|
5-day change | 1st Jan Change | |
91.96 CHF | -0.81% | -0.30% | +10.04% |
12:27pm | NOVARTIS AG : Deutsche Bank gives a Buy rating | MD |
07:00am | Big Pharma bets on AI to speed up clinical trials | RE |
Evolution of the average Target Price on Novartis AG
Price target over the last 5 years
History : Analyst Recommendations
a3906579ab89746.rl9t6FM1ZMlpGa3c0xFKQzdBBEoUlBKKXmCkYdJZ8zY.72tV3RhSNZZebefv5SQmclR4Ux1lx0a-Cj_nEqUuy3rAGCC5FnQQuTpK4A~57e0ad78ff62acfb91bf7663be23df26
More recommendations
Analysts' Consensus
Sell
Buy

Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
102.65USD
Average target price
113.28USD
Spread / Average Target
+10.36%
High Price Target
129.45USD
Spread / Highest target
+26.11%
Low Price Target
89.43USD
Spread / Lowest Target
-12.88%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Novartis AG
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
JEFFERIES | Peter Welford |
JPMORGAN | Richard Vosser |
BARCLAYS | Emily Field |
Barrington Research | |
AlphaValue | |
DZ Bank | |
UBS | Michael Leuchten |
Stifel Nicolaus | |
International Strategy & Investment Group | |
Credit Suisse | |
Morningstar | |
Kepler Capital Markets | |
ODDO BHF | |
GOLDMAN SACHS | Keyur Parekh |
BERENBERG | Kerry Holford |
DA Davidson | |
MORGAN STANLEY | Mark Purcell |
Zacks Equity Research | |
BNP Paribas | |
Bank of America Securities/Merrill Lynch | |
BERNSTEIN RESEARCH | Wimal Kapadia |
Kepler Cheuvreux | |
Wolfe Research | |
AltaCorp Capital | |
DEUTSCHE BANK | Emmanuel Papadakis |
HSBC | |
Exane BNP Paribas | |
Bryan, Garnier & Co. | |
Berenberg Bank | |
Deutsche Bank Securities | |
Moody's Investors Service | |
Dundee | |
Exane BNP | |
Bernstein | |
Argus | |
Cowen | |
BRYAN GARNIER | Eric Le Berrigaud |
LIBERUM CAPITAL | Graham Doyle |
BANK OF AMERICA (BOFA) | Graham Parry |
Trading Rating :
Investor Rating :
ESG Refinitiv :
B-